REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorios Lifarlit S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Laboratorios Lifarlit S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorios Lifarlit S.A. is based in Ecuador, with the head office in Guayaquil. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on November 15, 2005. The total number of employees is currently 11 (2023). There was a total growth of 1150% in Laboratorios Lifarlit S.A.’s total assets over the same period.

Headquarters
Av.42 y Calle 18 H// Av. 9na y Calle 4ta 400
Guayaquil; Guayas;

Contact Details: Purchase the Laboratorios Lifarlit S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Lifarlit S.A. report to view the information.
Outstanding Shares:
Purchase the Laboratorios Lifarlit S.A. report to view the information.
Registered Capital:
Purchase the Laboratorios Lifarlit S.A. report to view the information.
Incorporation Date:
November 15, 2005
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Laboratorios Lifarlit S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total assets
1150%
Total equity
1150%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?